Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2

Syncytium induction is a characteristic feature of infection by human immunodeficiency virus (HIV) in vitro. The hydrophobic amino terminus of the transmembrane glycoprotein of HIV type 1 is an essential determinant of virus entry into the target cell population and the formation of syncytia in cell culture. To define the role of the HIV type 2 fusion peptide during infection and syncytium formation, we introduced 8 amino acid substitutions into the hydrophobic amino terminus of gp41, changing either the hydrophobicity, the charge, or the polarity of the amino acid. Viruses containing the envelope mutations were analyzed for their syncytium-inducing capacities, levels of infectivity, and envelope processing and expression. Mutations that increased the hydrophobic nature of the fusion peptide increased syncytium formation, whereas mutations which increased the charge and the polarity and/or decreased the hydrophobicity of the fusion domain severely reduced the capacity of the virus to induce syncytia. However, viruses severely compromised for syncytium formation exhibit only slightly lower levels of infectivity.

[1]  L. Ratner,et al.  Demonstration of two distinct cytopathic effects with syncytium formation-defective human immunodeficiency virus type 1 mutants , 1991, Journal of virology.

[2]  R. Gallo,et al.  Dispensable role of the human immunodeficiency virus type 2 Vpx protein in viral replication , 1991, Journal of virology.

[3]  J. Sodroski,et al.  Attenuation of human immunodeficiency virus type 1 cytopathic effect by a mutation affecting the transmembrane envelope glycoprotein , 1991, Journal of virology.

[4]  B. Moss,et al.  Synthesis, oligomerization, and biological activity of the human immunodeficiency virus type 2 envelope glycoprotein expressed by a recombinant vaccinia virus. , 1990, Virology.

[5]  E. Freed,et al.  Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Sodroski,et al.  Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants , 1990, Journal of virology.

[7]  E. Tschachler,et al.  Functional contribution of cysteine residues to the human immunodeficiency virus type 1 envelope , 1990, Journal of virology.

[8]  T. Klimkait,et al.  A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations. , 1989, Virology.

[9]  P. Earl,et al.  Identification of the fusion peptide of primate immunodeficiency viruses. , 1989, Science.

[10]  L. Jagodzinski,et al.  Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[11]  B. Chesebro,et al.  Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity , 1988, Journal of virology.

[12]  J. Sodroski,et al.  Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. , 1987, Science.

[13]  W. Gallaher,et al.  Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus , 1987, Cell.

[14]  K. Steimer,et al.  Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein , 1986, Nature.

[15]  F. Brun-Vézinet,et al.  Isolation of a new human retrovirus from West African patients with AIDS. , 1986, Science.

[16]  J. Lifson,et al.  AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. , 1986, Science.

[17]  T. Waldmann,et al.  Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. , 1985, The New England journal of medicine.

[18]  Y. Vaishnav,et al.  The biochemistry of AIDS. , 1991, Annual review of biochemistry.

[19]  M. Waxham,et al.  Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. , 1987, AIDS research and human retroviruses.

[20]  J. Sodroski,et al.  Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity , 1986, Nature.